Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

sopresin
Connect with this vendor - Learn about this product

Sopersin - Vasopressin Injection IP

Sopersin

Medicine composition: Vasopressin Injection IP

Dosage Form: Injection

Packing: 1 injection

Market Authorization: MBA Pharmaceuticals Pvt Ltd

Country Of Origin: India

 

Vasopressin is indicated for prevention and treatment of postoperative abdominal distention, in abdominal roentgenography to dispel interfering gas shadows, and in diabetes insipidus.

Vasopressin should be used cautiously in the presence of epilepsy, migraine, asthma, heart failure, or any state in which a rapid addition to extracellular water may produce hazards for an already overburdened system.

Chronic nephritis with nitrogen retention contraindicates the use of vasopressin until reasonable nitrogen blood levels have been attained.